Anne Mongiu, MD
Colon & Rectal Surgery · New Haven, CTNPI 1356580575
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,225 of the $9,539 with a category attached, or 65.3%. 9 manufacturers reported payments, led by Medtronic at 45.2% of the total.
Across 28 payments — averaging $340.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Intuitive Surgical$3K
- Convatec Inc.$2K
- Medrobotics Inc.$221
- Axonics, Inc.$122
- Acell, Inc.$74
- plus $58 from 3 others
Across 11 payments — averaging $860.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$9K
What the payments were for
- Consulting fees$6,22565%
- Travel & lodging$1,34014%
- Food & beverage$7248%
- Education$1,25013%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 8 | $4,312 |
| Intuitive Surgical | 10 | $2,551 |
| Convatec Inc. | 1 | $2,200 |
| Medrobotics Inc. | 1 | $221 |
| Axonics, Inc. | 2 | $122 |
| Acell, Inc. | 3 | $74 |
| Shire North American Group Inc | 1 | $23 |
| THD America, Inc. | 1 | $18 |
| KCI USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,539 in reported general payments places this provider in the 85th percentile of 48 colon & rectal surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocortisone | 38 | $377 |
| Metronidazole | 26 | $130 |
| Neomycin Sulfate | 17 | $103 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in New Haven
- George YavorekNew Haven$45K
- Haddon PantelNew Haven$22K
- Hulda EinarsdottirNew Haven$2K
- Vikram ReddyNew Haven$561
- Walter LongoNew Haven$32
- John MonsonDanbury$182K
- Nicole SaurFairfield$36K
- Ryan BendlNorwalk$12K
- Marc CasasantaDanbury$11K
- Christine BartusNew Britain$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.